Computational approach to decode the mechanism of curcuminoids against neuropathic pain

Comput Biol Med. 2022 Aug:147:105739. doi: 10.1016/j.compbiomed.2022.105739. Epub 2022 Jun 23.

Abstract

Background: Curcumin (CUR), demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC) are the main components of turmeric that commonly used to treat neuropathic pain (NP). However, the mechanism of the therapy is not sufficiently clarified. Herein, network pharmacology, molecular docking and molecular dynamics (MD) approaches were used to investigate the mechanism of curcuminoids for NP treatment.

Methods: Active targets of curcuminoids were obtained from the Swiss Target database, and NP-related targets were retrieved from GeneCards, OMIM, Drugbank and TTD databases. A protein-protein interaction (PPI) network was built to screen the core targets. Furthermore, DAVID was used for GO and KEGG pathway enrichment analyses. Interactions between potential targets and curcuminoids were assessed by molecular docking and the MD simulations were run for 100ns to validate the docking results on the top six complexes.

Results: CUR, DMC, and BDMC had 100, 99 and 100 targets respectively. After overlapping with NP there were 33, 33 and 31 targets respectively. PPI network analysis of TOP 10 core targets, TNF, GSK3β were common targets of curcuminoids. Molecular docking and MD results indicated that curcuminoids bind strongly with the core targets. The GO and KEGG showed that curcuminoids regulated nitrogen metabolism, the serotonergic synapse and ErbB signaling pathway to alleviate NP. Furthermore, specific targets in these three compounds were also analysed at the same time.

Conclusions: This study systematically explored and compared the anti-NP mechanism of curcuminoids, providing a novel perspective for their utilization.

Keywords: Bisdemethoxycurcumin; Curcumin; Demethoxycurcumin; Molecular docking; Network pharmacology; Neuropathic pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Curcuma* / chemistry
  • Curcumin* / chemistry
  • Curcumin* / pharmacology
  • Databases, Factual
  • Diarylheptanoids* / chemistry
  • Diarylheptanoids* / pharmacology
  • ErbB Receptors / metabolism
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Molecular Docking Simulation*
  • Molecular Dynamics Simulation*
  • Molecular Targeted Therapy
  • Neuralgia* / drug therapy
  • Nitrogen / metabolism
  • Serotonin / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Diarylheptanoids
  • Tumor Necrosis Factor-alpha
  • bisdemethoxycurcumin
  • Serotonin
  • ErbB Receptors
  • Glycogen Synthase Kinase 3 beta
  • Curcumin
  • Nitrogen
  • demethoxycurcumin